Tag Archives: Martin Shkreli

Trump offloading drug price battle to new FDA chief; Dr. Gottlieb’s ideas make a lot of sense






The News: New FDA Commissioner Dr. Scott Gottlieb comes into office immediately confronted by a host of tough challenges: from budget concerns, drug prices, staffing issues and a nationwide opioid… Read more »

Trump win sends pharma stocks up, while hospitals plunge; fate of Obamacare far from clear






Pharmaceutical stocks and bonds were among the day’s biggest winners Wednesday (November 9, 2016) as the sweeping Republican victory in US elections eased concern that price controls might be imposed… Read more »

Ariad Pharma’s Slide Continues as Bernie Sanders Seeks Data on Leukemia Drug; Recent Drug Price Hikes Put Company on Familiar Hot Seat






Ariad Pharmaceuticals Inc. (Cambridge MA) continued to plummet Thursday (October 20, 2016) after Vermont Sen. Bernie Sanders and Maryland Rep. Elijah Cummings sent a letter to the company, demanding more information about… Read more »

Healthcare Stocks Tumble as Clinton’s Lead Widens; Are the Jitters Justified or Do Opportunities Abound?






Democratic presidential nominee Hillary Clinton has been named the culprit for beating down biotech stocks just for squealing about high drug prices on Twitter. Imagine the ever-increasing likelihood of her becoming the… Read more »

Mylan CEO Bent Truth About Epipen Profit; Sadly Follows Path of Valeant, Turing Pharma






Controversial Mylan NV (Amsterdam) CEO Heather Bresch was grilled in a marathon committee hearing about the EpiPen’s pricing before Congress last week. But it turns out that several of her… Read more »

Lawmakers Unimpressed with Mylan CEO’s Defense of EpiPen Pricing; Fact that She’s a Senator’s Daughter Not Beneficial






Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan NV (Amsterdam) about the significant cost increase of its life-saving EpiPens and the profits for a company with… Read more »

Painted as the Latest Pharma Scoundrel, Mylan’s CEO Bresch Isn’t Buying It; She’s Got a Point, Maybe






Last week Mylan pharmaceuticals CEO Heather Bresch seemingly attained a status of villainy synonymous with Lance Armstrong and, more recently, Ryan Lochte, with news stories of its fourfold price increase… Read more »

Mylan to Reduce Cost of EpiPen as Pressure Mounts; Not All Patients to Benefit






Mylan NV (Amsterdam) on Thursday took some steps to alleviate patients’ cost burden for its $600 EpiPen emergency allergy shots following pressure from politicians including presidential candidate Hillary Clinton, who… Read more »

U.S. Prescription Spending to Pass $610 Billion a Year by 2020 Says IMS Health






Spending on prescription drugs in the U.S. rose 12% to a record $425 billion before discounts last year, boosted in part by the introduction of breakthrough medicines for cancer and… Read more »